Articles

Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndrome

National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
Genomics Testing Cooperative laboratories;
Office of Biostatistics Research, National Institutes of Health;
Office of Biostatistics Research, National Institutes of Health;
Department of Laboratory Medicine, National Institutes of Health;
National Heart, Lung, and Blood Institute;
Hospital A Beneficiencia Portuguesa
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
National Heart, Lung, and Blood Institute;
Haematologica Early view May 21, 2020 https://doi.org/10.3324/haematol.2020.249995